Danaher Corporation $DHR Position Reduced by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 0.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,668,285 shares of the conglomerate’s stock after selling 5,133 shares during the quarter. Danaher accounts for 2.9% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s portfolio, making the stock its 9th largest position. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA owned about 0.24% of Danaher worth $330,754,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at $26,000. Howard Hughes Medical Institute acquired a new position in shares of Danaher during the second quarter worth about $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the third quarter worth about $28,000. Tripletail Wealth Management LLC acquired a new stake in shares of Danaher in the third quarter valued at about $31,000. Finally, Red Tortoise LLC raised its holdings in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Evercore ISI restated an “outperform” rating and issued a $250.00 price target on shares of Danaher in a report on Monday, January 5th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Robert W. Baird set a $247.00 price target on shares of Danaher in a report on Wednesday, October 22nd. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $249.92.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. This trade represents a 59.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 30,248 shares of company stock worth $6,609,663 over the last 90 days. Insiders own 11.10% of the company’s stock.

Danaher Stock Up 1.4%

Shares of Danaher stock opened at $238.28 on Monday. The business has a 50-day moving average price of $225.77 and a 200 day moving average price of $210.67. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The firm has a market cap of $168.31 billion, a P/E ratio of 49.13, a P/E/G ratio of 4.24 and a beta of 0.89. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 EPS for the quarter, topping the consensus estimate of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the firm earned $1.71 EPS. The business’s revenue was up 4.4% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is currently 26.39%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.